Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Larkin

Showing results (131-140 of 418) with videos related to

Pageof 42
Sort By:
BMC Medical Education|November 23, 2023
"Tell me what is 'better'!" How medical students experience feedback, through the lens of self-regulatory learningMuirne Spooner, James Larkin, Siaw Cheok Liew, et al.
Current Problems in Cancer|February 24, 2021
Pituitary enlargement following ipilimumab without long term endocrine dysfunctionEdson Nogueira, Arjun Menon, Anastasia Dede, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Isolated imbalance due to bilateral vestibular failure following immune checkpoint inhibitor administration: two casesSurangi Mendis, John Ealing, James Larkin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2020
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective AnalysisFrancesca Comito, Isla Leslie, Laura Boos, et al.
BJGP Open|August 8, 2025
Pharmaceutical company promotional payments to English general practices: longitudinal studyShai Mulinari, Minahil Malik, James Larkin, et al.
Anticancer Research|July 4, 2012
Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinomaJames Larkin, Norbert Esser, Emiliano Calvo, et al.
Translational Oncology|July 4, 2017
Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma PatientsSimon Matoori, Yeeliang Thian, Dow-Mu Koh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumabStefan Diem, Benjamin Kasenda, Juan Martin-Liberal, et al.
BMC Primary Care|February 27, 2025
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment componentJames Larkin, Louise Foley, Shane Timmons, et al.
Radiology|May 30, 2014
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinibYeeliang Thian, Andreas Gutzeit, Dow-Mu Koh, et al.
Pageof 42

Showing results (131-140 of 418) with videos related to

Sort By:
Pageof 42
BMC Medical Education|November 23, 2023
"Tell me what is 'better'!" How medical students experience feedback, through the lens of self-regulatory learningMuirne Spooner, James Larkin, Siaw Cheok Liew, et al.
Current Problems in Cancer|February 24, 2021
Pituitary enlargement following ipilimumab without long term endocrine dysfunctionEdson Nogueira, Arjun Menon, Anastasia Dede, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Isolated imbalance due to bilateral vestibular failure following immune checkpoint inhibitor administration: two casesSurangi Mendis, John Ealing, James Larkin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2020
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective AnalysisFrancesca Comito, Isla Leslie, Laura Boos, et al.
BJGP Open|August 8, 2025
Pharmaceutical company promotional payments to English general practices: longitudinal studyShai Mulinari, Minahil Malik, James Larkin, et al.
Anticancer Research|July 4, 2012
Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinomaJames Larkin, Norbert Esser, Emiliano Calvo, et al.
Translational Oncology|July 4, 2017
Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma PatientsSimon Matoori, Yeeliang Thian, Dow-Mu Koh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumabStefan Diem, Benjamin Kasenda, Juan Martin-Liberal, et al.
BMC Primary Care|February 27, 2025
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment componentJames Larkin, Louise Foley, Shane Timmons, et al.
Radiology|May 30, 2014
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinibYeeliang Thian, Andreas Gutzeit, Dow-Mu Koh, et al.
Pageof 42